ClinicalTrials.gg

Merck & Co., Inc: Triple Negative Breast Neoplasms trials

The registry lists 17 Triple Negative Breast Neoplasms studies with Merck & Co., Inc as lead sponsor. 3 are open to participants now and 11 have results posted.

Phase 1 6Phase 2 5Phase 3 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.